Mesoblast Limited vs D Wave Quantum Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while D Wave Quantum Inc trades at $17.94 (market cap $6.19B). The key difference: D Wave Quantum Inc is far larger — about 2.9× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| MESO | QBTS | |
|---|---|---|
Market Cap | $2.17B | $6.19B |
Sector | Technology | Technology |
52-Week High | $20.96 | $44.78 |
52-Week Low | $12.88 | $12.98 |
Enterprise Value | $2.17B | $5.65B |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →